R01 CA59005/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2006	2
2012	1
2013	1
2024	0

Page 1

CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.

Barry EL, Poole EM, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM. Barry EL, et al. Cancer Causes Control. 2013 Jan;24(1):47-54. doi: 10.1007/s10552-012-0088-6. Epub 2012 Oct 19. Cancer Causes Control. 2013. PMID: 23081681 Free PMC article. Clinical Trial.

Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).

Kim S, Baron JA, Mott LA, Burke CA, Church TR, McKeown-Eyssen GE, Cole BF, Haile RW, Sandler RS. Kim S, et al. Cancer Causes Control. 2006 Dec;17(10):1299-304. doi: 10.1007/s10552-006-0075-x. Cancer Causes Control. 2006. PMID: 17111262

Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.

Barry EL, Baron JA, Bhat S, Grau MV, Burke CA, Sandler RS, Ahnen DJ, Haile RW, O'Brien TG. Barry EL, et al. J Natl Cancer Inst. 2006 Oct 18;98(20):1494-500. doi: 10.1093/jnci/djj398. J Natl Cancer Inst. 2006. PMID: 17047198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year